- Recent Funding
- Investors
- Innovent Biologics
Innovent Biologics portfolio
Innovent Biologics has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is AnHeart Therapeutics's $61M Series B+ round in December 2021, alongside Octagon Capital Advisors, Cenova, Sage Partners and 1 other. That company is in Health and bio.
What Innovent Biologics invests in
- Health and bio · 1 · 100%
- Developer tools and cloud · 1 · 100%
How Innovent Biologics invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $61M |
Innovent Biologics portfolio companies
AAnHeart Therapeutics$61MSeries B+ · Dec 2021
| Company | Round with Innovent Biologics | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $61M | $81M | Dec 14, 2021 Series B+ |
Most frequent co-investors
LLaurion Capital Management1 shared round · last Dec 14, 2021
OOctagon Capital Advisors1 shared round · last Dec 14, 2021
CCenova1 shared round · last Dec 14, 2021
SSage Partners1 shared round · last Dec 14, 2021
Similar investors
FFounders Factory2 companies
LLayer Global3 companies · 2 deals in 12 mo
IIDEO CoLab Ventures4 companies · 1 deal in 12 mo
KKorelya Capital4 companies · 1 deal in 12 mo
MMPower Partners5 companies · 4 deals in 12 mo
SS Ventures5 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Innovent Biologics. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Innovent Biologics, which is a subset of its real portfolio. API: /api/v1/investors/innovent-biologics (get a free API key). More: the most active VC firms and new venture capital funds.